BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 6:16:00 PM | Browse: 1261 | Download: 1030
 |
Received |
|
2013-06-13 09:01 |
 |
Peer-Review Started |
|
2013-06-13 09:40 |
 |
To Make the First Decision |
|
2013-07-19 08:29 |
 |
Return for Revision |
|
2013-07-20 20:04 |
 |
Revised |
|
2013-07-30 01:49 |
 |
Second Decision |
|
2013-08-06 13:54 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-08-06 23:07 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-08-09 21:17 |
 |
Typeset the Manuscript |
|
2013-08-27 16:43 |
 |
Publish the Manuscript Online |
|
2013-09-11 10:40 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Infliximab for the treatment of pouchitis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Maddalena Zippi, Claudio Cassieri, Eleonora Veronica Avallone and Roberta Pica |
Funding Agency and Grant Number |
|
Corresponding Author |
Maddalena Zippi, MD, Unit of Gastroenterology and Digestive Endoscopy, Sandro Pertini Hospital, Via dei Monti Tiburtini 385, 00157 Rome, Italy. maddyzip@yahoo.it |
Key Words |
Ileal pouch-anal anastomosis; Infliximab; Pouchitis; Tumor necrosis factor-; Ulcerative colitis |
Core Tip |
Pouchitis represents the most frequent long term complication of the ileal pouch anal anastomosis and consists of an idiopathic nonspecific inflammation of the ileal mucosa of the pouch. Several studies show the effectiveness of treatment with anti-tumor necrosis factor-? in chronic forms in reducing the synthesis of pro-inflammatory molecules and in restoring the balance between pro-inflammatory and anti-inflammatory cytokines. |
Publish Date |
2013-09-11 10:40 |
Citation |
Zippi M, Cassieri C, Avallone EV, Pica R. Infliximab for the treatment of pouchitis. World J Clin Cases 2013; 1(6): 191-196 |
URL |
http://www.wjgnet.com/2307-8960/full/v1/i6/191.htm |
DOI |
http://dx.doi.org/10.12998/wjcc.v1.i6.191 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345